Milestone Scientific to Present at the H.C. Wainwright BioConnect 2022 Conference
January 07 2022 - 9:00AM
Milestone Scientific Inc. (NYSE:MLSS), a leading
developer of computerized drug delivery instruments that provide
painless and precise injections, today announced that Arjan
Haverhals, Chief Executive Officer of Milestone Scientific, will be
presenting at the H.C. Wainwright BioConnect 2022 Conference being
held virtually January 10-13, 2022.
Milestone’s presentation will be available on-demand to
registered attendees via the conference platform beginning Monday,
January 10, 2022 at 7:00 AM Eastern Time.
The webcast of the Company’s presentation can be accessed here:
https://journey.ct.events/view/d3b75f3c-73e8-45e2-9fc6-d8c0229c9ed5
and on the investor relations section of the Milestone website at
https://www.milestonescientific.com/investors as of 7:00 AM Eastern
Time on Monday, January 10, 2022.
About Milestone Scientific
Inc.Milestone Scientific Inc. (MLSS) is a technology
focused medical research and development company that patents,
designs and develops innovative injection technologies and
instruments for medical, dental and cosmetic applications.
Milestone Scientific’s computer-controlled systems are designed to
make injections precise, efficient and increase the overall patient
comfort and safety. Their proprietary DPS Dynamic Pressure Sensing
Technology® instruments is the platform to advance the development
of next-generation devices, regulating flow rate and monitoring
pressure from the tip of the needle, through platform extensions of
subcutaneous drug delivery, including local anesthetic. To learn
more, view Milestone Scientific’s brand video or visit
milestonescientific.com.
Safe Harbor Statement
This press release contains forward-looking statements regarding
the timing and financial impact of Milestone's ability to implement
its business plan, expected revenues, timing of regulatory
approvals and future success. These statements involve a number of
risks and uncertainties and are based on assumptions involving
judgments with respect to future economic, competitive and market
conditions, future business decisions and regulatory developments,
all of which are difficult or impossible to predict accurately and
many of which are beyond Milestone's control. Some of the important
factors that could cause actual results to differ materially from
those indicated by the forward-looking statements are general
economic conditions, failure to achieve expected revenue growth,
changes in our operating expenses, adverse patent rulings, FDA or
legal developments, competitive pressures, changes in customer and
market requirements and standards, and the risk factors detailed
from time to time in Milestone's periodic filings with the
Securities and Exchange Commission, including without limitation,
Milestone's Annual Report for the year ended December 31, 2020. The
forward-looking statements in this press release are based upon
management's reasonable belief as of the date hereof. Milestone
undertakes no obligation to revise or update publicly any
forward-looking statements for any reason.
Contact: David Waldman or Natalya
RudmanCrescendo Communications, LLCEmail: mlss@crescendo-ir.comTel:
212-671-1020
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Milestone Scientific (AMEX:MLSS)
Historical Stock Chart
From Sep 2023 to Sep 2024